A substantial amount of work has been completed to investigate which miRNAs are differentially expressed in myeloma [132–134], and it has been shown that miRNA changes can deregulate genes and pathways relevant to myeloma pathogenesis including cell cycle progression, TP53 and MYC [135–137]. Here, MYC is linked to plasma cell myeloma.